<DOC>
	<DOC>NCT01533532</DOC>
	<brief_summary>The purpose of this study is to evaluate the efficacy and safety of KLH-2109 in patients with endometriosis.</brief_summary>
	<brief_title>A Randomized, Placebo-controlled, Double-blind Study of KLH-2109 in Patients With Endometriosis (2)</brief_title>
	<detailed_description />
	<mesh_term>Endometriosis</mesh_term>
	<criteria>Female patients with endometriosis Patients with clinically significant hepatic, renal, or cardiovascular dysfunction</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>Gonadotropin-Releasing Hormone (GnRH) antagonist</keyword>
</DOC>